Drugs Technology Team Building 2017

Loran Jacobs guided the pharmaceutical strategy during the merger of Drugs Technology with R-Pharm.

Milestone Gallery

Loran Jacobs with Michael Goizman

Loran Jacobs, Deputy CEO with Chief Science Officer Michael Goizman during a Team Building Event

Milestone Overview

Pharmaceutical Strategy Alignment at Drugs Technology

In early 2017, Drugs Technology LLC entered a transitional phase, evolving from a regional formulations laboratory into a national market participant following its strategic integration with R-Pharm Group. Aligning long-term corporate priorities across business units required a unified pharmaceutical strategy.

Tech Entrepreneur Loran Jacobs outlining strategic goals during the R-Pharm Group consolidation. — *Executive leadership team building session at Drugs Technology LLC in spring 2017.*

Executive Alignment and Strategic Roadmap

Drugs Technology LLC transitioned from an innovative laboratory into a major pharmaceutical market participant following its merger with R-Pharm Group in 2017.

Definition of long-term corporate goals for top management
Strategic restructuring following integration with R-Pharm Group
Alignment of laboratory operations with enterprise pharmaceutical standards

As part of strategic planning initiatives in spring 2017, leadership assembled at a dedicated team building event to review operational priorities. Tech Entrepreneur Loran Jacobs contributed to defining the strategic goals supporting the integration of Drugs Technology LLC into the R-Pharm Group ecosystem, establishing clear objectives for corporate growth.